Skip to main content
Supplement ScienceSupplementScience

Types of Glutathione (Liver Support): Forms & Bioavailability

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
Liposomal GlutathioneHigh (liposomal encapsulation protects from GI degradation)Best oral form — liposomes deliver intact GSH to the bloodstream, bypassing digestive breakdown
S-Acetyl GlutathioneModerate-High (acetyl group improves stability)Stable oral form — acetylated for better GI survival; deacetylated intracellularly to active GSH
Reduced Glutathione (L-Glutathione)Low (extensively broken down in GI tract)Budget option — most affordable but poor absorption; higher doses needed
N-Acetylcysteine (NAC) — PrecursorModerate (provides rate-limiting cysteine for GSH synthesis)Proven precursor strategy — well-studied, affordable way to raise hepatic glutathione levels

Liposomal Glutathione

Bioavailability: High (liposomal encapsulation protects from GI degradation). Best for: Best oral form — liposomes deliver intact GSH to the bloodstream, bypassing digestive breakdown.

S-Acetyl Glutathione

Bioavailability: Moderate-High (acetyl group improves stability). Best for: Stable oral form — acetylated for better GI survival; deacetylated intracellularly to active GSH.

Reduced Glutathione (L-Glutathione)

Bioavailability: Low (extensively broken down in GI tract). Best for: Budget option — most affordable but poor absorption; higher doses needed.

N-Acetylcysteine (NAC) — Precursor

Bioavailability: Moderate (provides rate-limiting cysteine for GSH synthesis). Best for: Proven precursor strategy — well-studied, affordable way to raise hepatic glutathione levels.

Full Glutathione (Liver Support) Guide

References

  1. ReviewHayes JD, Flanagan JU, Jowsey IR (2005). Glutathione transferases. Annual Review of Pharmacology and Toxicology. DOI PubMed
  2. Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT (1979). Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. DOI PubMed
  3. ObservationalHonda Y, Kessoku T, Sumida Y, Kobayashi T, Kato T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, Kataoka K, Taguri M, Yamanaka T, Seko Y, Tanaka S, Saito S, Ono M, Oeda S, Eguchi Y, Aoi W, Sato K, Itoh Y, Nakajima A (2017). Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterology. DOI PubMed
  4. ReviewLu SC (2013). Glutathione synthesis. Biochimica et Biophysica Acta. DOI PubMed
  5. Meta-analysisMohideen K, Jeddy N, Krithika C, Faizee SH, et al. (2023). Assessment of glutathione peroxidase enzyme response and total antioxidant status in oral cancer - Systematic review and meta-analysis.. Cancer reports (Hoboken, N.J.). DOI PubMed
  6. Meta-analysisLee N, Park SM, Yee J, Yoon HY, et al. (2020). Association Between Glutathione-S-Transferase Gene Polymorphisms and Responses to Tyrosine Kinase Inhibitor Treatment in Patients with Chronic Myeloid Leukemia: A Meta-analysis.. Targeted oncology. DOI PubMed
  7. Meta-analysisZhang M, Wu SQ, He JQ (2019). Are genetic variations in glutathione S-transferases involved in anti-tuberculosis drug-induced liver injury? A meta-analysis.. Journal of clinical pharmacy and therapeutics. DOI PubMed
Show 4 more references
  1. Meta-analysisLiu WZ, Sun Y, Feng X, Bi XH, et al. (2018). An updated meta-analysis for association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer.. Journal of cancer research and therapeutics. DOI PubMed
  2. Meta-analysisHuang M, Zeng Y, Zhao F, Huang Y (2018). Association of glutathione S-transferase M1 polymorphisms in the colorectal cancer risk: A meta-analysis.. Journal of cancer research and therapeutics. DOI PubMed
  3. Meta-analysisZhou T, Li HY, Xie WJ, Zhong Z, et al. (2018). Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility.. BMC cancer. DOI PubMed
  4. Meta-analysisWang H, Gao X, Zhang X, Gong W, et al. (2018). Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.. Medical science monitor : international medical journal of experimental and clinical research. DOI PubMed